Use of Acetyl Salicylic Acid and Terbutalin in Assisted Reproductive Techniques (ART)

Use of Acetylsalicylic Acid and Terbutalin in ART

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00518141

Enrollment

300

Registered

2007-08-20

Start date

2006-03-31

Completion date

2009-05-31

Last updated

2011-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Reproductive Techniques, Assisted

Brief summary

This study aims to determine the possible effects of Acetyl Salicylic Acid (ASA) and Terbutalin on ART treatment.

Detailed description

This study aims to determine the possible effects of ASA and Terbutalin on ART treatment.

Interventions

DRUGAcetyl Salicylic Acid and Terbutalin

ASA 75 mg, Terbutalin 5mg

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

FEMALE

Age

18 Years to 39 Years

Healthy volunteers

Inclusion criteria

* Infertile women below 39 years of age

Exclusion criteria

* Women who may react allergically to the drugs administered * Women with hyperthyroid or IDDM * Women who do not want to participate in the study * Women who are unable to give informed, written consent.

Design outcomes

Primary

Measure	Time frame
Pregnancy	7 weeks

Countries

Norway

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026